CCI Clears Advent International’s Rs 3,150 Crore Investment in Yatharth Hospital

The Competition Commission of India (CCI) has approved Advent International’s proposed Rs 3,150 crore investment in Yatharth Hospital and Trauma Care Services, clearing a key regulatory step for the Private Equity firm’s entry into the healthcare provider. Advent is making the investment through its affiliate, Rasmalai Ltd, and is expected to acquire a 24.9% minority stake after the transaction is completed.

The investment was announced by Yatharth Hospital in September as a primary capital infusion. The proposed deal is expected to provide the hospital chain with funds to support its expansion plans and strengthen its healthcare network, while giving Advent greater exposure to India’s hospital and healthcare services market.

Key Highlights of the Advent-Yatharth Hospital Deal

• CCI has approved Advent International affiliate Rasmalai Ltd’s proposed investment in Yatharth Hospital.
• The transaction involves a Rs 3,150 crore primary capital infusion.
• Advent is expected to acquire a 24.9% minority stake in the healthcare provider.
• The investment is intended to support Yatharth Hospitals’ expansion and strengthen its healthcare network.
• Yatharth operates nine multi-speciality hospitals with 2,800 beds and an announced capacity of 3,250 beds.

CCI Approves Rs 3,150 Crore Investment in Yatharth Hospital

The CCI has cleared the proposed acquisition of a shareholding in Yatharth Hospital and Trauma Care Services by Rasmalai Ltd, an affiliate of US-based private equity firm Advent International.

In its announcement, the competition regulator confirmed that it had approved the acquisition of certain shareholding in the listed healthcare company. The approval removes an important regulatory hurdle for the proposed investment.

Transactions involving shareholding acquisitions that meet specified regulatory thresholds require CCI approval. The regulator examines such deals to assess their potential impact on competition in the relevant markets.

Advent International to Acquire 24.9% Minority Stake

Advent International is investing Rs 3,150 crore through Rasmalai Ltd under a definitive agreement announced by Yatharth Hospital in September. Once the transaction is completed, Advent is expected to hold a 24.9% minority stake in the company.

The investment is structured as primary capital, meaning the funds are intended to go into the company rather than being described as a purchase of existing shares from current shareholders.

Rasmalai Ltd is incorporated in Cyprus and has investment-holding as its principal activity. The entity currently has no activities or presence in India, according to the information provided in the transaction announcement.

How Yatharth Hospital Plans to Use the Investment

The Rs 3,150 crore capital infusion is expected to provide Yatharth Hospital with financial resources to pursue its expansion plans. The company intends to strengthen its healthcare network and expand its presence in the hospital services market.

For a hospital operator, additional capital can support the development of medical infrastructure, expansion of hospital capacity and improvements to healthcare services. However, the specific projects and allocation of the investment will depend on the company’s expansion plans and subsequent decisions.

The deal also gives Advent an opportunity to increase its exposure to India’s healthcare sector, where demand for hospital and specialised medical services has supported the expansion of organised healthcare providers.

Yatharth Hospital’s Network and Healthcare Operations

Based in Noida, Yatharth Hospital and Trauma Care Services operates a network of multi-speciality and super-speciality hospitals. Its facilities provide healthcare services, diagnostic support and advanced medical procedures across multiple specialities.

Founded in 2008, the company has developed a presence across North India and is among the region’s growing listed healthcare providers. It operates nine multi-speciality hospitals with a total of 2,800 beds and an announced capacity of 3,250 beds.

The difference between current bed capacity and announced capacity highlights the scale of the company’s hospital network. Further expansion and utilisation of capacity will be important factors in its future operating performance.

Yatharth Hospital Reports Higher September Quarter Profit

Yatharth Hospital reported a 17.45% year-on-year increase in consolidated net profit to Rs 48.45 crore for the September quarter. The company had recorded a consolidated profit of Rs 41.25 crore in the corresponding period of the previous year.

Revenue from operations increased to Rs 431.42 crore during the quarter, according to the company’s reported financial results. These figures indicate growth in both profit and operating revenue compared with the year-ago period.

The latest financial performance provides additional context for the investment announcement, although the proposed capital infusion and the company’s quarterly results are separate developments.

Why CCI Approval Matters for the Transaction

The Competition Commission of India is responsible for examining transactions that fall within its merger-control framework. Its role is to assess whether acquisitions and combinations could adversely affect competition in the relevant markets.

By approving Advent’s proposed investment in Yatharth Hospital, the regulator has cleared the transaction at this stage. The approval is an important step, but completion of the investment remains subject to the applicable transaction terms and other required procedures.

The deal also reflects continued private equity interest in India’s organised healthcare sector. Investments in hospital businesses can provide expansion capital, while investors gain exposure to a sector with significant infrastructure and service requirements.

What the Advent Investment Means for India’s Healthcare Sector

The proposed investment brings a large private equity commitment into a listed hospital operator with an established network in North India. For Yatharth Hospital, the capital could support efforts to expand its facilities and strengthen its position in the healthcare services market.

For Advent International, the expected 24.9% minority stake represents an investment in India’s hospital industry through a company that already operates multiple healthcare facilities.

The long-term impact will depend on how effectively Yatharth deploys the capital, expands its hospital network and manages operating performance. The company’s ability to translate additional investment into sustainable growth will remain an important factor for shareholders and the wider healthcare market.

Conclusion

CCI’s approval of Advent International affiliate Rasmalai Ltd’s proposed Rs 3,150 crore investment marks an important step in the transaction involving Yatharth Hospital and Trauma Care Services. Advent is expected to acquire a 24.9% minority stake through the primary capital infusion.

The investment is intended to support Yatharth’s expansion plans and strengthen its healthcare network. With nine hospitals, 2,800 existing beds and an announced capacity of 3,250 beds, the company has an established operating base from which to pursue further growth. The transaction’s ultimate impact will depend on its completion and the effective deployment of the new capital.